Evaluation of safety and pharmacokinetics of sodium 2,2 dimethylbutyrate, a novel short chain fatty acid derivative, in a phase 1, double-blind, placebo-controlled, single-dose, and repeat-dose studies in healthy volunteers. (Q37524864)
Jump to navigation
Jump to search
scientific article published on 21 March 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Evaluation of safety and pharmacokinetics of sodium 2,2 dimethylbutyrate, a novel short chain fatty acid derivative, in a phase 1, double-blind, placebo-controlled, single-dose, and repeat-dose studies in healthy volunteers. |
scientific article published on 21 March 2011 |
Statements
Evaluation of safety and pharmacokinetics of sodium 2,2 dimethylbutyrate, a novel short chain fatty acid derivative, in a phase 1, double-blind, placebo-controlled, single-dose, and repeat-dose studies in healthy volunteers (English)
William A Wargin
Michael S Boosalis
Wayne J Wallis
Sally Case
Jeffrey R Keefer
Douglas V Faller
William C Welch
Ronald J Berenson
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference